BiO2 Medical Gets $6.7M

San Antonio-based BiO2 Medical, a developer of products to prevent blood clots from reaching the lungs, has raised $6.7M in an ongoing, $7.5M funding round, according to a regulatory filing from the firm. Source of the new funding was not disclosed. BiO2 Medical has previously raised funding from Targeted Technology Fund I and the Texas Emerging Technology Fund. The regulatory filing indicates that there were 57 investors who participated in the latest funding. More information »